Tyra Biosciences (TYRA) Earnings Analysis

Tyra Biosciences (TYRA) next reports earnings on 2026-08-13, consensus EPS -0.67 USD. Last quarter (2026-03-02) it missed with EPS -0.57 USD vs -0.54 USD est (-5.6%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E -14.03.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does TYRA next report earnings?

Next earnings date2026-08-13
Consensus EPS estimate-0.67 USD
Revenue estimaten/a

TYRA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-02-0.57 USD-0.54 USD-5.6%Miss
2025-08-14-0.47 USD-0.53 USD+11.3%Beat
2025-05-08-0.47 USD-0.49 USD+4.1%Beat

Beat rate: 2/3 (67%) over reported quarters with consensus data.

TYRA valuation and analyst view

Trailing P/E-14.03
Trailing EPS-2.12329 USD
Price / book4.87
Dividend yield0.00%
Market cap1.86B
Analyst consensusBuy (7 buy / 0 hold / 0 sell)
Avg price target47 USD

Related research pages

Frequently asked questions

When is Tyra Biosciences (TYRA)'s next earnings date?

Tyra Biosciences is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.67 USD.

Did TYRA beat earnings last quarter?

In its 2026-03-02 report, TYRA posted EPS of -0.57 USD versus a -0.54 USD estimate — a miss of 5.6%.

What is TYRA's earnings track record?

Over the last 3 reported quarters with consensus data, TYRA beat estimates 2 times (67%).

What is TYRA's current P/E ratio and EPS?

TYRA trades at a trailing P/E of -14.03 on trailing EPS of -2.1232937167640684 USD.

What do analysts rate TYRA?

Analyst consensus is "Buy" across 7 ratings (0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 47 USD.